HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$0.85
Day range
$0.80 - $0.85
Year range
$0.80 - $7.14
Market cap
2.73M USD
Avg Volume
652.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.42M | 58.00% |
Net income | -3.38M | -62.57% |
Net profit margin | — | — |
Earnings per share | -1.03 | 35.62% |
EBITDA | -3.42M | -57.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.89M | -57.85% |
Total assets | 4.94M | -38.86% |
Total liabilities | 1.22M | 33.51% |
Total equity | 3.72M | — |
Shares outstanding | 3.27M | — |
Price to book | 0.75 | — |
Return on assets | -136.52% | — |
Return on capital | -171.93% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.38M | -62.57% |
Cash from operations | -3.60M | -104.58% |
Cash from investing | -3.24K | -16.86% |
Cash from financing | 926.20K | 1,855.95% |
Net change in cash | -2.68M | -47.52% |
Free cash flow | -2.36M | -127.80% |
About
Founded
2011
Headquarters
Website
Employees
13
